Epclusa

Epclusa is a combination medication containing Sofosbuvir and Velpatasvir, used for treating chronic hepatitis C. This oral medication is designed to target the virus and support recovery.

Epclusa is primarily used for the treatment of chronic hepatitis C virus (HCV) infection. It works by targeting the virus to help the immune system fight the infection. This medication is often prescribed for adults with or without cirrhosis, aiding in the management of HCV.

Common effects of Epclusa may include fatigue, headache, and nausea. Some individuals might experience insomnia or diarrhea. These effects vary and are not experienced by everyone taking the medication.

Epclusa should be used with caution in individuals with liver problems other than hepatitis C. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Always follow the advice of a healthcare professional.

Epclusa may interact with other medications, including certain anticonvulsants, HIV medications, and some antibiotics. It is crucial to discuss all current medications with a healthcare provider to ensure safe use.